A share price of Health Catalyst Inc [HCAT] is currently trading at $4.07, up 0.25%. An important factor to consider is whether the stock is rising or falling in short-term value. The HCAT shares have gain 11.20% over the last week, with a monthly amount drifted -10.55%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Health Catalyst Inc [NASDAQ: HCAT] stock has seen the most recent analyst activity on April 09, 2025, when Evercore ISI downgraded its rating to a In-line. Previously, KeyBanc Capital Markets upgraded its rating to Overweight on January 08, 2025, and kept the price target unchanged to $9. On April 10, 2024, downgrade downgraded it’s rating to Sector Weight. Evercore ISI upgraded its rating to a Outperform but stick to its price target of $11 on January 03, 2024. Barclays initiated its recommendation with a Overweight and recommended $14 as its price target on January 03, 2024. JP Morgan upgraded its rating to Overweight for this stock on December 13, 2023, and downed its price target to $11. In a note dated November 13, 2023, Piper Sandler upgraded an Overweight rating on this stock and revised its target price from $12 to $11.
Health Catalyst Inc experienced fluctuations in its stock price throughout the past year between $3.56 and $9.24. Currently, Wall Street analysts expect the stock to reach $5.67 within the next 12 months. Health Catalyst Inc [NASDAQ: HCAT] shares were valued at $4.07 at the most recent close of the market. An investor can expect a potential return of 39.31% based on the average HCAT price forecast.
Analyzing the HCAT fundamentals
Trailing Twelve Months sales for Health Catalyst Inc [NASDAQ:HCAT] were 306.58M which represents 6.02% growth. Gross Profit Margin for this corporation currently stands at 0.39% with Operating Profit Margin at -0.2%, Pretax Profit Margin comes in at -0.23%, and Net Profit Margin reading is -0.23%. To continue investigating profitability, this company’s Return on Assets is posted at -0.08, Equity is -0.19 and Total Capital is -0.11. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.69.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.98 points at the first support level, and at 3.88 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.16, and for the 2nd resistance point, it is at 4.24.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Health Catalyst Inc [NASDAQ:HCAT] is 1.42. On the other hand, the Quick Ratio is 1.42, and the Cash Ratio is 0.77. Considering the valuation of this stock, the price to sales ratio is 0.93, the price to book ratio is 0.71.
Transactions by insiders
Recent insider trading involved LeSueur Daniel, Chief Operating Officer, that happened on Apr 03 ’25 when 5209.0 shares were sold. Officer, DANIEL LESUEUR completed a deal on Apr 03 ’25 to buy 10418.0 shares. Meanwhile, General Counsel Landry Benjamin sold 13827.0 shares on Mar 06 ’25.
